TNFRSF17 expression was restricted to plasma cell high tumours regardless of the presence of other tumour-infiltrating lymphocytes (T cells, memory B cells) and linked to an improved survival in ovarian cancer [74]. The gene discussed is TNFRSF17; the disease is ovarian carcinoma.